Molecular diagnosis is performed at the gene level with nucleic acids as the object for detection, with high sensitivity and accuracy.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

The diagnostics space is rapidly changing and growing. In May,a sessionon Center Stage at MDM East will address some of these changes in the in vitro diagnostics market along with fast growth markets and disruptive trends. We haveidentified

Illumina and China firm Boai NKY Medical Holdings have partnered to develop next-generation sequencing-based hereditary disease tests in China. Under the agreement announced on Tuesday, NKY and Illumina will develop an NGS system based on I

Illumina has filed a lawsuit against BGI Group subsidiary Latvia MGI Tech in the Dsseldorf Regional Court in Germany, alleging that BGIs sequencing products and related reagents infringe a patent Illumina holds in Europe, EP 1 530 578 B1, w

Grifols said on Thursday that it will acquire a 26.2 percent stake in Shanghai RAAS as part of a strategic alliance agreement to manufacture, market, and develop plasma products and transfusion diagnostic solutions in the Chinese market. Un

The global urinalysis market is expected to grow at a CAGR of 7.5% from 2018 to 2022 to reach a value of USD 2.14 billion by 2022, driven by a large base of the target population and increasing demand for urinalysis due to unmet clinical ne

German firm Cytena announced today that it has raised 3 million ($3.4 million) in a Series A financing round. The firm will use the funding to expand its sales activities, as well as further develop and explore potential applications for it

Beckman Coulter Life Sciences (Indianapolis, IN, USA) has entered into a partnership with Apostle Inc. (Menlo Park, CA, USA) for the launch of Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit, a magnetic nanoparticle-based kit to

Baxter International Inc. and bioMrieux announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI). The announcement was made at the International Symposium on Inte

Abbott announced today that it has received CE marking for its Alinity m molecular diagnostics system and assays, which are now available in countries that recognize the designation. The firm said that its molecular system will help clinici

A recentstudyconcluded that a first-of-its-kind magnetic surgical system allows a safe, reproducible, incision-less technique for port-less intraabdominal mobilization. The Magnetic Surgical System, developed by Levita Magnetics, is so unlik